NEW YORK, Aug. 29, 2014 /PRNewswire/ -- Faruqi &
Faruqi, LLP, a leading national securities law firm, reminds
investors in InVivo Therapeutics Holdings Corp. ("InVivo" or the
"Company") (OTC: NVIV) of the October 6,
2014 deadline to seek the role of lead plaintiff in a
federal securities class action lawsuit filed against InVivo and
certain executives.
A complaint has been filed in the United States District Court
of Massachusetts on behalf of all
persons who purchased or acquired InVivo securities between
April 5, 2013 through August 26, 2013, inclusive (the "Class
Period").
The complaint alleges that the Company and its executives
violated federal securities laws with respect to its disclosures
concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period,
the Company failed to disclose the timeframe within which its
first-in-man clinical study for its biopolymer scaffolding product
would be complete and data submitted to the United States Food and
Drug Administration ("FDA").
On August 27, 2013, the Company
announced that it would need at least 24 months from the date of
the first enrolled patient to complete clinical trials for its
biopolymer scaffold product.
Following this news, the price of InVivo stock declined by
$1.37, or roughly 40%, to close at
$2.07 on August 27, 2014.
Request more information now by clicking here:
www.faruqilaw.com/NVIV. There is no cost or obligation to
you.
Take Action
If you invested in InVivo stock or options
between April 5, 2013 through
August 26, 2013 and would like to
discuss your legal rights, visit www.faruqilaw.com/NVIV. You
can also contact us by calling Richard
Gonnello toll free at 877-247-4292 or at 212-983-9330 or by
sending an e-mail to rgonnello@faruqilaw.com. Faruqi &
Faruqi, LLP also encourages anyone with information regarding
InVivo's conduct to contact the firm, including whistleblowers,
former employees, shareholders and others.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The
firm is focused on providing exemplary legal services in complex
litigation in the areas of securities, shareholder, antitrust and
consumer litigation, throughout all phases of litigation. The
firm has an experienced trial team which has achieved significant
victories on behalf of the firm's clients. To keep track of the
latest securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or
predict a similar outcome with respect to any future matter.
We welcome the opportunity to discuss your particular case.
All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello,
Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
SOURCE Faruqi & Faruqi, LLP